Awarded
TRASTUZUMABUM EMTASINUM - pulb. pt.conc. pt. sol. perf. 100 mg - 15 ml
- Contract value
- RON 1,953,606
- Bids received
- 6
- Published
- 22 Sept 2026
- Awarded
- 7 Apr 2023
- Contract start
- 7 Apr 2023
- Contract end
- 7 Apr 2024estimated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| PANITUMUMABUM - conc. pt. sol. perf. 20mg/ml - 100 mg - 5 ml | SPITALUL ORASENESC NEGRESTI OAS | ALLIANCE HEALTHCARE ROMÂNIA SRL, FILDAS TRADING, MEDIPLUS EXIM | RON 458,714 | 22 Sept 2026 |
| TRASTUZUMABUM - pulb. pt. conc. pt. sol perf. - 150 mg | SPITALUL ORASENESC NEGRESTI OAS | DONA. LOGISTICA, FILDAS TRADING, MEDIPLUS EXIM | RON 156,752 | 22 Sept 2026 |
| AVELUMABUM - conc. pt. Sol. Perf. - 20mg/ml - 10ml | SPITALUL ORASENESC NEGRESTI OAS | FARMEXIM S.A., MEDIPLUS EXIM | RON 3,344,848 | 22 Sept 2026 |
| DURVALUMABUM - conc.pt.sol.perf. 50 mg/ml - (500mg) - 10 ml | SPITALUL ORASENESC NEGRESTI OAS | ALLIANCE HEALTHCARE ROMÂNIA SRL, FARMEXIM S.A., MEDIPLUS EXIM | RON 3,507,625 | 22 Sept 2026 |
| DOXORUBICINUM - conc. pt. sol. perf. 2 mg/ml - 10 ml (caelyx) | SPITALUL ORASENESC NEGRESTI OAS | ALLIANCE HEALTHCARE ROMÂNIA SRL | RON 61,889 | 22 Sept 2026 |
| DURVALUMABUM - conc.pt.sol.perf. 50 mg/ml - (120mg) - 2,4 ml | SPITALUL ORASENESC NEGRESTI OAS | ALLIANCE HEALTHCARE ROMÂNIA SRL, FARMEXIM S.A., MEDIPLUS EXIM | RON 842,722 | 22 Sept 2026 |